Escitalopram for psychological symptoms and cardiovascular outcomes in patients with coronary heart disease: a systematic review and meta-analysis of randomized controlled trials.
BMC cardiovascular disorders · 2026
Abstract e pubblicazione originale
L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.
Leggi nella fonte originale ↗Parole chiave
HumansCoronary DiseaseTreatment OutcomeRisk FactorsDepressionAnxietyRandomized Controlled Trials as TopicEscitalopramSelective Serotonin Reuptake InhibitorsMeta-analysisCoronary Heart DiseaseMajor Adverse Cardiovascular EventsCoronary heart diseaseMajor adverse cardiovascular events
Come citare questo studio
Wang X, Tan Y, Hu S, Pan B, Qiu W, Wang C, Zhou G, Luo Q, Qian J. (2026). Escitalopram for psychological symptoms and cardiovascular outcomes in patients with coronary heart disease: a systematic review and meta-analysis of randomized controlled trials.. BMC cardiovascular disorders. DOI: 10.1186/s12872-026-06389-1
Consulta la pubblicazione originale ↗